C12N 2795/14122
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2795/14122 (New viral proteins or individual genes, new structural or functional aspects of) appears on 61 US grants and 72 published applications in this corpus.
Search patents in C12N- Granted patents
- 61
- Published applications
- 72
- Assignees
- 51
- Inventors
- 144
- Latest grant
- 4 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 7 | 0 |
| 1999 | 0 | 0 |
| 2000 | 4 | 0 |
| 2001 | 1 | 1 |
| 2002 | 1 | 1 |
| 2003 | 0 | 5 |
| 2004 | 0 | 2 |
| 2005 | 1 | 1 |
| 2006 | 3 | 1 |
| 2007 | 1 | 2 |
| 2008 | 1 | 2 |
| 2009 | 0 | 3 |
| 2010 | 0 | 4 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 3 | 1 |
| 2014 | 1 | 1 |
| 2015 | 1 | 1 |
| 2016 | 2 | 4 |
| 2017 | 2 | 3 |
| 2018 | 2 | 4 |
| 2019 | 2 | 9 |
| 2020 | 5 | 5 |
| 2021 | 6 | 6 |
| 2022 | 2 | 2 |
| 2023 | 3 | 6 |
| 2024 | 3 | 1 |
| 2025 | 4 | 2 |
| 2026 | 0 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- M13 phage based gene therapy platform4 Nov 2025US 12,458,674 B2Massachusetts Institute of Technology
- Methods and compositions for display of macrocyclic peptides15 Jul 2025US 12,359,192 B2University of Rochester
- General amyloid interaction motif (GAIM)11 Mar 2025US 12,247,055 B2Amyl Therapeutics SRL
- Virus-based piezoelectric energy generation4 Feb 2025US 12,218,609 B2The Regents of the University of California
- Compositions of and methods for in vitro viral genome engineering27 Feb 2024US 11,913,032 B2C3J Therapeutics, Inc.
- Engineered bacteriophage particle and method of gene therapy by using same8 Oct 2026US 2026/0308626 A1Academia Sinica
- Microporous carbon nanofibers27 Aug 2026US 2026/0253906 A1Massachusetts Institute of Technology
- Use of modified phage for capturing and subtyping of cancer cells26 Feb 2026US 2026/0056202 A1The Chinese University of Hong Kong
- M13 bacteriophages displaying peptide motifs targeting amyloid-beta, methods and uses thereof19 Feb 2026US 2026/0048090 A1Universidade Do Minho
- Production of biological scalable nanorods2 Oct 2025US 2025/0304919 A1Massey Ventures Limited
Most cited
By later US patents
- Directed evolution of novel binding proteins2,450US 5,223,409 AProtein Engineering Corporation · 1993
- Viruses expressing chimeric binding proteins1,136US 5,403,484 AProtein Engineering Corporation · 1995
- Directed evolution of novel binding proteins1,057US 5,571,698 AProtein Engineering Corporation · 1996
- Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants660US 5,750,373 AGenentech, Inc. · 1998
- Monovalent phage display562US 5,821,047 AGenentech, Inc. · 1998